NCT03181763View on ClinicalTrials.gov

Evaluation of MDMA on Startle Response

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
Startle Response
Interventions
DRUG

Placebo

Participants will receive inactive placebo on their second visit.

DRUG

Midomafetamine

Participants will receive 100 mg midomafetamine HCl on their second visit

BEHAVIORAL

Acoustic startle

Startle assessment

Trial Locations (1)

30329

Emory University, Atlanta

Sponsors

Lead Sponsor

Lykos Therapeutics
All Listed Sponsors
lead

Lykos Therapeutics

INDUSTRY